Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date An impurity detected in a stability study... Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe Full Title: An impurity detected in a stability study: Did we miss anything in our E&L risk assessment? Extractable and leachable (E&L) testing are r... 1 year ago | 90 mins Conducting successful commercial research in a primary care setting Simon Royal. NIHR; Rebecca Clarke, Layton Medical Centre; Jonathan Abraham, Healum; Sheena Gomez, GlaxoSmithKline The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine r... 12 months ago | 61 mins #SciValFest2020 - KE: How industry uses bibliometrics to inform collaborations Malcolm Skingle CBE, PhD - Director of Academic Liaison, GlaxoSmithKline & Dr Lesley Thompson, Elsevier Some of the current scientific challenges that we are attempting to solve are so large that we need to engage multi-disciplinary teams across a variet... 2 years ago | 40 mins The Evolution of DataOps at GSK (GlaxoSmithKline) Chuck Smith - VP of Data Strategy - GlaxoSmithKline | Bryan Duxbury - Chief Technologist - StreamSets GlaxoSmithKline is a pharmaceutical company that has pioneered a transformation of its R&D data and analytics infrastructure. Creating a new drug can ... 4 years ago | 58 mins Manufacturing in the Industry 4.0 era... Christos Varsakelis at GlaxoSmithKline Biologicals SA & Mark Demesmaeker, at Sartorius & Roger-Marc Nicoud at Ypso-Facto Full Title: Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted The manufacturing status quo ... 2 years ago | 112 mins Powering Connections that Matter with Kong’s Full Lifecycle Service Control Plat Kong CEO Augusto Marietti and GlaxoSmithKline Director of Software Engineering Odean Maye We’re on the cusp of a hyper-connected world where more than a trillion devices will be connected in order to power the driverless cars and robotic ph... 3 years ago | 16 mins Automation of Study Design and Delivery Lifecycle to Increase Efficiency Chibby Ebhogiaye, Business Optimization Owner, GlaxoSmithKline,Evi Cohen, VP, Global Life Sciences & Healthcare, Appian Join Appian as we sit down with GlaxoSmithKline and discuss automation of study design and delivery lifecycle for life sciences organizations, and how... 2 years ago | 50 mins Data-driven Marketing Strategies in an Economic Downturn Emad Hasan, CEO, Retina and Allison Hartsoe, CEO of Ambition Data and author of The Age of Customer Equity The world is changing. Coming out of a pandemic, with inflation rising and an economic slowdown—or downturn—possibly on the horizon, data-driven strat... 9 months ago | 61 mins Identification of unknown extractables and leachables using mass spectrometry... Petra Booij, Investigator at GlaxoSmithKline & Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific Full Title: Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence? Extractable and Leachable ... 3 years ago | 58 mins Identification of unknown extractables and leachables using mass spectrometry... Petra Booij, Investigator at GlaxoSmithKline & Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific Full Title: Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence? Extractable and Leachable ... 3 years ago | 57 mins Load more
